AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ERYTECH Pharma S.A.

Declaration of Voting Results & Voting Rights Announcements Mar 9, 2016

1295_dva_2016-03-09_b1f13940-045b-4877-b227-6f05fc46cc7d.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Information related to total number of voting rights and shares composing the share capital - February 2016

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France

Listing market: Euronext Paris from Euronext Market segment : segment B

ISIN Code : FR0011471135

website : www.erytech.com

Date Total of shares composing
the share capital
Total of brut(1) voting
rights
Total of net(2) voting
rights
31 January 2016 7 924 611 9 706 437 9 703 937
29 February 2016 7 931 781 9 713 607 9 711 107

(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares

Talk to a Data Expert

Have a question? We'll get back to you promptly.